Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Saturday
Mar 13th
Home arrow Farmavita.Net Journal arrow Business Reports
Farmavita.Net - Business Reports
Print E-mail
Market Report

datamonitor_logo.gif

New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency

With industry consolidation, the economic downturn, and an increasing threat from generics, pharma companies are coming under greater pressure to fill their pipelines with innovative drugs. However, despite the costs and risks involved in drug development, the pharma industry is finding new ways to streamline the R&D process in an effort to increase efficiency and output.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Osteoporosis - Novel agents to battle for payer acceptance

Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong performance of the bisphosphonate class.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Acute Leukemias - Persistent unmet needs confer significant commercial opportunity

While existing treatment strategies for adult acute leukemia may yield satisfactory remission- induction rates, a major clinical concern is the high rate of disease relapse despite attempts to optimize post-remission consolidation therapy. This is acutely problematic among elderly patients who are frequently unable to tolerate the rigors of more intensive treatment approaches.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis

This report provides comprehensive coverage of every class of drugs across major cardiovascular indications and profiles the underlying trends and factors driving the market. Detailed insights into recent key events and future market leaders are also provided, in addition to epidemiological analysis and forecasts for major products over the 2007-13 period.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Diabetes to the fore as generics hit primary care markets

Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2017. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major markets.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

Commercial strategies in cardiovascular and metabolic diseases-successful market positioning at company and brand level becomes paramount

Datamonitor expects commercial strategies in the cardiovascular and metabolic markets to become increasingly important as the markets mature. The report details strategies used by pharmaceutical companies to capture market share, to differentiate brands from the competition, for revenue maximization and for the defense of brand revenues from generic competition.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

Technology Transfer Strategies: Maximizing the returns from new technologies

Technology transfer is a long-established part of early-stage research within the pharmaceutical and biotechnology industries. Although technology transfer offices have traditionally been associated with inefficiency and a lack of commercial judgment, recent trends have shown improvements in staffing, expertise and service levels.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities

Autoimmune disorders have been one of the most prominent growth segments in the pharma industry over the last decade. A growing patient population and high levels of unmet need are the main drivers of market growth, and novel biologics are increasingly helping to fulfill patient need, with their high cost helping to drive market sales.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

Market developments, outsourcing hotspots and growth strategies

This report aims to identify the hotspots and profile the leading players in the global pharmaceutical contract manufacturing market.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 55 - 63 of 324
Advertisement
  • Networking Tips & Tricks

    Monitoring comments about specific product

    You can easily monitor comments about offer and demand specifically interesting for you.  On the Comments bar (below main article) click on the RSS button and bookmark this RSS feed.

     
  • Latest Published
 

Featured Video

More videos ...

3D Content Cloud

Featured Partners

farmavita_research-store.gif
top-20-cancer-therapy-brand.jpg
generics-growth-strategies2.gif
sfe_eu10_150x150_v2.gif 
mddexeceu10_150x150_v1.gif
discovery2010_150x150.gif
150x150_salesonco-master.gif
pharma_omaeu10_150x150_v2.gif
risksharingnextlevel.gif 
arriello-150x150.gif 
150x150_ceepr3_master.gif 
pharmabrand2010_150x150.gif
 

Login to Farmavita.Net

membership is FREE

Follow us on:

bpe_oglas.gif




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 3 guests online

Farmavita.Net RSS News


Products

Click to Products

JobLine

Click here ...Post a Job for Free

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS